Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

AKYA Akoya BioSciences Inc

2,66

0,00 (0,00%)

09 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Akoya BioSciences Charts.

Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Akoya BioSciences Charts.

News Akoya BioSciences Inc

Form 8-K - Current report
Freitag 13 Dezember 2024 (4 Wochen vor) • Edgar (US Regulatory)

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions
Dienstag 10 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone
Montag 9 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 21 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Akoya Biosciences Reports Third Quarter 2024 Financial Results
Donnerstag 14 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel
Dienstag 5 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Montag 4 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Akoya BioSciences Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen